TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Vaccination Växjö AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
702
|
695
|
510 |
| Financial expenses |
1
|
2
|
0 |
| Earnings before taxes |
141
|
130
|
77 |
| EBITDA |
141
|
132
|
77 |
| Total assets |
513
|
430
|
329 |
| Current assets |
148
|
122
|
53 |
| Current liabilities |
55
|
64
|
23 |
| Equity capital |
423
|
336
|
279 |
| - share capital |
5
|
4
|
5 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
82.5%
|
78.1%
|
84.8% |
| Turnover per employee |
702
|
695
|
510 |
| Profit as a percentage of turnover |
20.1%
|
18.7%
|
15.1% |
| Return on assets (ROA) |
27.7%
|
30.7%
|
23.4% |
| Current ratio |
269.1%
|
190.6%
|
230.4% |
| Return on equity (ROE) |
33.3%
|
38.7%
|
27.6% |
| Change turnover |
5
|
226
|
56 |
| Change turnover % |
1%
|
48%
|
12% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.